Lakshmi Narayanan

Business over the last 9-10 years, and I'm just looking at the comparison of Q1 of FY 19 or FY18 with the Q1 which we reported now. The growth has been around, and I would say, on an overall basis, 3-4% on Indian rupee terms. Now comparably, if you look at the U.S. enzyme market per se has actually grown at even at 7% or 6% on a U.S. dollar basis.

Am I clear now? Or is it still a problem, sir?

Yeah. Am I audible now?